Transcriptome Analysis of mRNA in Uterine Leiomyoma Using Next-Generation RNA Sequencing.
Uterine leiomyoma is a benign smooth muscle tumor of monoclonal nature in female reproductive tract and is one of the major health problems. More than 70% of female population suffers from uterine leiomyoma in their lifetime and in advanced condition it is associated with pregnancy complications and infertility. Characterization and relative expression of mRNA transcripts through transcriptome profiling in uterine leiomyoma and adjacent myometrium. Uterine leiomyoma tissue of an Indian female, age 32 years, with family history of leiomyoma (evident from mother's hysterectomy for the same pathology) was used. Patient showed 9 multiple large lesions appearing heterogeneously, deforming the uterine contour and causing distortion and splaying of the endometrial cavity showing disease aggressiveness was taken for Next-generation sequencing (NGS) to develop whole transcriptome profile along with the adjacent myometrium as control. The validation of the relative expression of the selective transcripts was done using Real-Time PCR. The transcriptome profile indicated 128 genes up-regulated and 98 down-regulated, with the Log2 fold change ≥ 2 and P ≤ 0.05, highlighting the molecular network closely associated with focal adhesion, hyaluronan and MAPK-signaling pathways. The mean relative fold change obtained from quantitative PCR as well as the P-values of 10 selected transcripts evaluated from student's t-test were as follows: BCAN: 7.93 fold (p value =0.0013); AAK1: 2.2 fold (p value =0.0036); PCBP3: 3.4 fold (p value =0.0197); MOV10L1: 3.4 fold (p value =0.0062); TWISTNB: 1.8 fold (p value =0.006); TMSB15A: 2.1 fold (p value =0.0023); SMAD1: 0.8 fold (p value =0.0112); ANXA1: 0.6 fold (p value =0.0012); FOS: 0.6 fold (p value =0.0191); SLFN11: 0.56 fold (p value =0.0001). The present study provides a roadmap, towards the analysis of genes and their roles in corresponding pathways throwing light on their possible involvement in the pathology of the disease.